Building our US Business Development Function AI-powered clinical decision and population health support for cardiometabolic disease Metadvice is an AI-powered clinical intelligence platform for cardiometabolic disease – hypertension, dyslipidaemia, type 2 diabetes, PCOS (PMOS), chronic kidney disease, heart failure and atrial fibrillation. Our technology is capable of handling co-morbidities and often detects conditions long before…
In May 2026, the international medical community reached a significant milestone: Polycystic Ovary Syndrome (PCOS) was officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). More than a change in terminology, the new name reflects a fundamental shift in how the condition is understood – from a disorder viewed primarily through a reproductive lens to a complex endocrine…
Since February 2023, two UK clinics gradually rolled out three modules — hypertension (HTN), type 2 diabetes (DM2), hypercholesterolemia (HCL) — with a clinical usage that was systematically monitored (by Metadvice) for diagnosis and therapies so that the recommendations can now be linked with observable outcomes (stored by Electronic Medical Record systems, EMR independent from…